adalimumab

Ligand id: 4860

Name: adalimumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: adalimumab

Immunopharmacology Comments
Adalimumab is an anti-TNFα immunosuppresive drug.
Immunopharmacology Disease
Disease X-Refs Comment References
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
Anti-TNFα monoclonal antibody therapy approved for RA
Ankylosing spondylitis Disease Ontology: DOID:7147
Anti-TNFα monoclonal antibody therapy approved for ankylosing spondylitis.
Psoriasis Disease Ontology: DOID:8893
Anti-TNFα monoclonal antibody therapy approved for psoriatic arthritis and plaque psoriasis.
Crohn's disease Disease Ontology: DOID:8778
OMIM: 266600
Orphanet: ORPHA206
Anti-TNFα monoclonal antibody therapy approved for Crohn's disease.